Calcium sulfate/hydroxyapatite bone graft substitute (CaS/HA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Calcium sulfate/hydroxyapatite bone graft substitute (CaS/HA), covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: FARE Augmentation of Proximal Femoral Fractures With CaS/HA and Systemic ZA [Phase 4]